BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34358968)

  • 21. 25-hydroxycholesterol promotes RANKL-induced osteoclastogenesis through coordinating NFATc1 and Sp1 complex in the transcription of miR-139-5p.
    Zhang L; Lv Y; Xian G; Lin Y
    Biochem Biophys Res Commun; 2017 Apr; 485(4):736-741. PubMed ID: 28257846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.
    Jules J; Wang S; Shi Z; Liu J; Wei S; Feng X
    J Biol Chem; 2015 Sep; 290(39):23738-50. PubMed ID: 26276390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pulsed electromagnetic fields on the expression of NFATc1 and CAII in mouse osteoclast-like cells.
    He J; Zhang Y; Chen J; Zheng S; Huang H; Dong X
    Aging Clin Exp Res; 2015 Feb; 27(1):13-9. PubMed ID: 24869857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.
    Matsumoto M; Kogawa M; Wada S; Takayanagi H; Tsujimoto M; Katayama S; Hisatake K; Nogi Y
    J Biol Chem; 2004 Oct; 279(44):45969-79. PubMed ID: 15304486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
    Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
    Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
    Odkhuu E; Koide N; Haque A; Tsolmongyn B; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
    Immunol Lett; 2012 Feb; 142(1-2):34-40. PubMed ID: 22193059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.
    Kim Y; Sato K; Asagiri M; Morita I; Soma K; Takayanagi H
    J Biol Chem; 2005 Sep; 280(38):32905-13. PubMed ID: 16046394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells.
    Kavitha CV; Deep G; Gangar SC; Jain AK; Agarwal C; Agarwal R
    Mol Carcinog; 2014 Mar; 53(3):169-80. PubMed ID: 23115104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
    Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
    J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis.
    Choi HK; Kang HR; Jung E; Kim TE; Lin JJ; Lee SY
    Cell Res; 2013 Apr; 23(4):524-36. PubMed ID: 23478294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective entry into mitosis 1 (Dim1) negatively regulates osteoclastogenesis by inhibiting the expression of nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1).
    An D; Kim K; Lu W
    J Biol Chem; 2014 Aug; 289(35):24366-73. PubMed ID: 25023277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.
    Kogawa M; Hisatake K; Atkins GJ; Findlay DM; Enoki Y; Sato T; Gray PC; Kanesaki-Yatsuka Y; Anderson PH; Wada S; Kato N; Fukuda A; Katayama S; Tsujimoto M; Yoda T; Suda T; Okazaki Y; Matsumoto M
    J Biol Chem; 2013 Oct; 288(43):31299-312. PubMed ID: 23990468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K.
    Lange AW; Yutzey KE
    Dev Biol; 2006 Apr; 292(2):407-17. PubMed ID: 16680826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
    Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
    Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
    Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.
    Yu M; Moreno JL; Stains JP; Keegan AD
    J Biol Chem; 2009 Nov; 284(47):32968-79. PubMed ID: 19801646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells.
    Roccisana JL; Kawanabe N; Kajiya H; Koide M; Roodman GD; Reddy SV
    J Biol Chem; 2004 Mar; 279(11):10500-7. PubMed ID: 14699143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.